PMID- 27932186 OWN - NLM STAT- MEDLINE DCOM- 20170426 LR - 20181202 IS - 1873-2623 (Electronic) IS - 0041-1345 (Linking) VI - 48 IP - 9 DP - 2016 Nov TI - Late Graft Rejection in Association With T-Large Granular Lymphocyte Expansion of Recipient Origin After Human Leukocyte Antigen-Haploidentical Stem Cell Transplantation: A Case Report. PG - 3222-3224 LID - S0041-1345(16)30329-3 [pii] LID - 10.1016/j.transproceed.2016.06.037 [doi] AB - BACKGROUND: Large granular lymphocyte (LGL) expansion occasionally occurs after allogeneic stem cell transplantation (allo-SCT), and is thought to be a good prognostic sign that is associated with a lower relapse rate. However, there have been no reports of late graft failure (LGF) due to graft rejection in association with oligoclonal LGL expansion. We herein report a case of LGF associated with the transient expansion of recipient-derived T-LGL after allo-SCT. CASE REPORT: A 65-year-old man underwent peripheral blood stem cell transplantation (PBSCT) from his human leukocyte antigen (HLA)-haploidentical son for the treatment of acute myeloid leukemia, which had evolved from a myelodysplastic syndrome (MDS). Neutrophil engraftment occurred on day 20. A chimerism analysis on day 29 showed both granulocytes and mononuclear cells in the peripheral blood to be completely of donor origin. However, his neutrophil count gradually decreased and a chimerism analysis on day 61 showed that 84% of the patient's T cells were of recipient origin while the granulocytes were 100% donor-derived. His LGLs rapidly increased to 4.01 x 10(9)/L on day 113 and decreased thereafter. The percentage of donor cells in his granulocytes gradually decreased, and the patient's leukocytes were completely replaced by recipient cells on day 177. CONCLUSIONS: The clinical course suggests that the expansion of recipient-derived T-LGLs after allo-SCT can be a sign of graft rejection. Early intervention may be needed if the LGL expansion is recipient-derived. CI - Copyright A(c) 2016 Elsevier Inc. All rights reserved. FAU - Nakagawa, N AU - Nakagawa N AD - Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. FAU - Yamazaki, H AU - Yamazaki H AD - Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. FAU - Aoki, G AU - Aoki G AD - Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. FAU - Kondo, Y AU - Kondo Y AD - Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. FAU - Nakao, S AU - Nakao S AD - Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. Electronic address: snakao8205@staff.kanazawa-u.ac.jp. LA - eng PT - Case Reports PT - Journal Article PL - United States TA - Transplant Proc JT - Transplantation proceedings JID - 0243532 RN - 0 (HLA Antigens) RN - 0 (Histocompatibility Antigens Class II) SB - IM MH - Aged MH - Chimerism MH - Female MH - Graft Rejection/*immunology MH - Graft vs Host Disease/*immunology MH - HLA Antigens/analysis MH - Histocompatibility Antigens Class II MH - Humans MH - Leukemia, Myeloid, Acute/*surgery MH - Male MH - Peripheral Blood Stem Cell Transplantation/*adverse effects MH - T-Lymphocytes/immunology/*pathology MH - Tissue Donors MH - Transplantation, Homologous/adverse effects EDAT- 2016/12/10 06:00 MHDA- 2017/04/27 06:00 CRDT- 2016/12/10 06:00 PHST- 2016/02/03 00:00 [received] PHST- 2016/04/28 00:00 [revised] PHST- 2016/06/21 00:00 [accepted] PHST- 2016/12/10 06:00 [entrez] PHST- 2016/12/10 06:00 [pubmed] PHST- 2017/04/27 06:00 [medline] AID - S0041-1345(16)30329-3 [pii] AID - 10.1016/j.transproceed.2016.06.037 [doi] PST - ppublish SO - Transplant Proc. 2016 Nov;48(9):3222-3224. doi: 10.1016/j.transproceed.2016.06.037.